Hydroxychloroquine Delays Disability for Least Treatable Form of Multiple Sclerosis

Hydroxychloroquine shows promise for reducing some of the debilitating systems associated with primary progressive multiple sclerosis, a new study reports. A University of Calgary study…

View More Hydroxychloroquine Delays Disability for Least Treatable Form of Multiple Sclerosis

Exercise Therapy Has Positive Effect on Multiple Sclerosis-Related Fatigue

Exercise is an effective therapeutic strategy for fatigue in patients with multiple sclerosis (MS), and combined exercise is the most effective modality for physical and…

View More Exercise Therapy Has Positive Effect on Multiple Sclerosis-Related Fatigue

Ocrelizumab Beneficial for Relapse Risk and Disability in Multiple Sclerosis

Ocrelizumab, a humanized anti-CD20 immunoglobulin G (IgG) antibody, may effectively control the risk of relapse and disability worsening in patients with multiple sclerosis (MS), according…

View More Ocrelizumab Beneficial for Relapse Risk and Disability in Multiple Sclerosis

SARS-CoV-2 Severity, Outcomes Linked to Age and Multiple Sclerosis Subtype

Patients with multiple sclerosis (MS) and SARS-CoV-2 were at increased risk for severe disease and mortality if they were of advanced age and had progressive…

View More SARS-CoV-2 Severity, Outcomes Linked to Age and Multiple Sclerosis Subtype
Immunizations in Multiple Sclerosis

Structural, Functional MRI Measures Improve Prediction of MS Long-Term Worsening

The integration of structural and functional magnetic resonance imaging (MRI) measures significantly improved prediction of long-term clinical worsening in patients with multiple sclerosis (MS), according…

View More Structural, Functional MRI Measures Improve Prediction of MS Long-Term Worsening

The Changing Guidelines on the Role of MRI in Multiple Sclerosis Management

The 2021 Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS), Consortium of Multiple Sclerosis Centres (CMSC), North American Imaging in Multiple Sclerosis Cooperative (NAIMS), provided updated…

View More The Changing Guidelines on the Role of MRI in Multiple Sclerosis Management

Emerging Research Provides Insight in Secondary Progressive MS

To date, there has yet to be established clear clinical, imaging, pathological, or immunological criteria to mark the transition from relapse-remitting multiple sclerosis (RRMS) to…

View More Emerging Research Provides Insight in Secondary Progressive MS